Source:http://linkedlifedata.com/resource/pubmed/id/21246611
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2011-5-13
|
pubmed:abstractText |
Despite advances in surgical technique, rotator cuff repairs are plagued by a high rate of failure. This failure rate is in part due to poor tendon-to-bone healing; rather than regeneration of a fibrocartilaginous attachment, the repair is filled with disorganized fibrovascular (scar) tissue. Transforming growth factor beta 3 (TGF-?3) has been implicated in fetal development and scarless fetal healing and, thus, exogenous addition of TGF-?3 may enhance tendon-to-bone healing. We hypothesized that: TGF-?3 could be released in a controlled manner using a heparin/fibrin-based delivery system (HBDS); and delivery of TGF-?3 at the healing tendon-to-bone insertion would lead to improvements in biomechanical properties compared to untreated controls. After demonstrating that the release kinetics of TGF-?3 could be controlled using a HBDS in vitro, matrices were incorporated at the repaired supraspinatus tendon-to-bone insertions of rats. Animals were sacrificed at 14-56 days. Repaired insertions were assessed using histology (for inflammation, vascularity, and cell proliferation) and biomechanics (for structural and mechanical properties). TGF-?3 treatment in vivo accelerated the healing process, with increases in inflammation, cellularity, vascularity, and cell proliferation at the early timepoints. Moreover, sustained delivery of TGF-?3 to the healing tendon-to-bone insertion led to significant improvements in structural properties at 28 days and in material properties at 56 days compared to controls. We concluded that TGF-?3 delivered at a sustained rate using a HBDS enhanced tendon-to-bone healing in a rat model.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1554-527X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Orthopaedic Research Society.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1099-105
|
pubmed:meshHeading |
pubmed-meshheading:21246611-Animals,
pubmed-meshheading:21246611-Biomechanics,
pubmed-meshheading:21246611-Bone and Bones,
pubmed-meshheading:21246611-Cicatrix,
pubmed-meshheading:21246611-Disease Models, Animal,
pubmed-meshheading:21246611-Drug Delivery Systems,
pubmed-meshheading:21246611-Injections, Intralesional,
pubmed-meshheading:21246611-Male,
pubmed-meshheading:21246611-Rats,
pubmed-meshheading:21246611-Rats, Sprague-Dawley,
pubmed-meshheading:21246611-Rotator Cuff,
pubmed-meshheading:21246611-Tendon Injuries,
pubmed-meshheading:21246611-Transforming Growth Factor beta3,
pubmed-meshheading:21246611-Wound Healing
|
pubmed:year |
2011
|
pubmed:articleTitle |
Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model.
|
pubmed:affiliation |
Department of Orthopaedic Surgery, Washington University, 660 South Euclid, Campus Box 8233, St. Louis, Missouri 63110, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|